Meeting Report

Published in:
Volume 5 / Year 2016 / Issue 4

Data requirements to demonstrate biosimilarity in the EU

Page: 182-4

Abstract: How has the European Medicines Agency (EMA) changed its requirements for biosimilars since it first approved biosimilars in 2006? This is the question Dr Martina Weise, Head of Licensing… Read More »

Go Back Print